Liquid Biopsy Market 2027 By Applications, Types And Top Key Players

South Africa
Posted by ellena on 01-04-21
Liquid Biopsy Market 2027 By Applications, Types And Top Key Players

Increasing cancer prevalence globally will boost the growth of the global market for liquid biopsy over the coming years. Market Size – USD 1.28 Billion in 2019, Market Growth - CAGR of 13.6%, Market Trends–High demand from developing nations.

The global liquid biopsy market size was valued at USD 1.28 billion in 2019 and is forecasted to reach USD 3.55 billion by 2027 at a CAGR of 13.6%. With a large number of ongoing trials witnessing positive outcomes, the Market is positioned over the forecast period to walk along a healthy growth track. Classification of metastatic breast cancers for monitoring and therapy is expected to be the most popular application of liquid biopsy for years to come.

The latest market intelligence study on the Liquid Biopsy Market covers the performance of both the key vendors and new entrants for the forecast period, 2020 - 2027. Estimated value, profits, gross margin, spending power and consumption volume form an important part of the study that aims at offering the business owners, stakeholders, and marketing personnel a competitive edge over others. Importantly, the study discusses a lot about, the product application, classification and performance across different regions. The industry assessment report weighs upon the top performers and also the winning strategies that have enabled them to occupy a strong foothold in the Liquid Biopsy Market.

Read [email protected]

Key Highlights From The Report

Based on sample type, other bio fluids generated a revenue of USD 0.17 billion in 2019 and is projected to rise with a CAGR of 11.8% in the forecast period, as saliva and plasma sample provides advantages such as quick assessment of patient health status for accurate cancer diagnosis.

The multi-gene-parallel analysis is expected to grow with a CAGR of 13.8% in the forecasted period, as it helps oncologists to steer patients through the detection of genetic aberrations through targeted therapy, which can be described as a significant step towards systematic cancer genome research.

The therapy selection for metastatic breast cancer application is the major contributor to the Liquid Biopsy Market. The therapy selection for metastatic breast cancer application of the North America region is the major shareholder of the market and held around 41.9% of the market in the year 2019.

North America dominated the market for Liquid Biopsy in 2019. The region's consistent focus on cost-effective and innovative procedures that are adopted in the area is driving the market. The North America region held approximately 51.2% of the market, followed by Europe, which contains around 25.0% market in the year 2019.

Major Companies

• RainDance Technologies
• Personal Genome Diagnostics
• Adaptive Biotechnologies
• NeoGenomics Laboratories
• Guardant Health
• Cynvenio
• Biocept
• Qiagen
• Trovagene
• Hoffmann-La Roche Ltd.

You Can Download Free Sample PDF Copy of Liquid Biopsy Market at

Segments Covered in this Report

Sample Type Outlook (Kilo Tons) (Revenue, USD Billion; 2017-2027)
Blood Sample-based
Urine Sample-based
Other Bio Fluids-based
Technology Outlook (Kilo Tons) (Revenue, USD Billion; 2017-2027)
Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)
Application Outlook (Kilo Tons) (Revenue, USD Billion; 2017-2027)
Therapy Selection for Metastatic Breast Cancer
Therapy Selection for Other Metastatic Cancer
Molecular Health Monitoring
Regional Outlook (Kilo Tons) (Revenue, USD Billion; 2017-2027)
North America
Asia Pacific
Latin America

Table of Content

Chapter 1. Methodology & Sources
    1.1. Market Definition
    1.2. Research Scope
    1.3. Methodology
    1.4. Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
    1.5. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Liquid Biopsy Market Segmentation & Impact Analysis
    4.1. Liquid Biopsy Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
           Rising application of liquid biopsy due to increasing prevalence of cancers
           Growing interest in liquid biopsy
          4.2.3. Market restraints analysis
           Unclear reimbursement and regulatory scenario associated with liquid biopsy
Chapter 5. Liquid Biopsy Market By Sample Type Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)
Chapter 6. Liquid Biopsy Market By Technology Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 7. Liquid Biopsy Market By Application Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 8. Liquid Biopsy Market Regional Outlook
Chapter 9. Competitive Landscape
Chapter 10. Company Profiles

  Send Message

Report this ad

Related ads